Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,511.48 9.83 0.06%
S&P 500 1,877.01 1.62 0.09%
NASDAQ 4,146.23 19.26 0.47%
Ticker Volume Price Price Delta
STOXX 50 3,170.90 -5.07 -0.16%
FTSE 100 6,683.16 8.42 0.13%
DAX 9,483.01 -61.18 -0.64%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope



Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories
                         Under StockCall's Microscope

PR Newswire

LONDON, April 16, 2013

LONDON, April 16, 2013 /PRNewswire/ --

Last year, patents on several blockbuster drugs expired, leading to increasing
competition from generic drugs. The trend is expected to continue in 2013. In
fact, rising competition from generic drugs is a major concern for drug
manufacturers such as Amarin Corporation Plc (NASDAQ: AMRN), Pharmacyclics
Inc. (NASDAQ: PCYC), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Start
Scientific Inc. (NASDAQ: STSI), and Impax Laboratories Inc. (NASDAQ: IPXL).
Shares of all five companies fell in Monday's trading session as the broad
market saw its biggest one-day drop following the release of some
disappointing economic data in the U.S. and China. StockCall has released full
comprehensive research on AMRN, PCYC, ANTH, STSI, and IPXL and these free
technical analyses can be downloaded by signing up at

http://www.stockcall.com/technicalanalysis

Amarin Corporation Plc's shares were among the major losers in the healthcare
sector yesterday. The stock fell to an intra-day low of $7.15 before finishing
the day 5.63% lower at $7.21 on volume of 3.10 million. Amarin's shares have
fallen nearly 10.90% so far in 2013, even as the broad market has posted
significant gains. The stock is currently trading well below its 50-day and
200-day moving averages, which is a bearish signal. Free technical analysis on
AMRN available by signing up at

http://www.StockCall.com/AMRN041613.pdf

Shares of Pharmacyclics Inc.'s shares fell sharply on Monday, extending their
losses from previous trading sessions. The stock closed 3.87% lower at $72.51
on volume of 723,300, taking its losses in the last three sessions to nearly
6.50%. Despite the recent losses, the company's shares have gained nearly
25.50% thus far in the year. However, the stock has recently slipped below its
50-day moving average, which indicates that market sentiment has turned
bearish on the stock. Register today and access the free research on PCYC at

http://www.StockCall.com/PCYC041613.pdf

Shares of Anthera Pharmaceuticals Inc. slipped yesterday. The stock closed
2.81% lower at $0.615 on volume of 711,400. Anthera's shares have fallen more
than 3.10% in the last three trading sessions. the major drug maker's shares
have traded sideways since February, struggling to break through $0.65
resistance level. The stock currently has strong support at around $0.60.
Shares of ANTH are currently trading below their 50-day and 200-day moving
averages, which is a bearish signal. The free report on ANTH can be downloaded
by signing up now at

http://www.StockCall.com/ANTH041613.pdf

Star Scientific Inc. saw a huge selloff in Monday's trading session. Shares of
the Glen Allen, Virginia-based company fell 8.78% to finish the day at $1.35
on volume of 1.57 million. The stock has fallen 10.6% in the last three
sessions. Star Scientific's shares have seen a series of lows since the start
of this year, which is a bearish signal. The stock has fallen nearly 50% so
far in 2013. Free report on STSI can be accessed by registering at

http://www.StockCall.com/STSI041613.pdf

Shares of Impax Laboratories Inc. fell sharply on Monday. The stock ended the
day 2.25% lower at $16.09 on volume of 706,900. Impax Laboratories' shares
have fallen nearly 21.50% so far in 2013, compared to a gain of over 8.80% for
the S&P 500. The stock is trading nearly 41% below its 52-week high. The
company's shares are also trading below their 50-day and 200-day moving
averages. Register with StockCall and download the research on IPXL for free
at

http://www.StockCall.com/IPXL041613.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com

Contact: Contact Person: William T. Knight, Email: info@stockcall.com, Contact
Number: +1(646) 396-9857 (9:00 am EST - 01:30 pm EST)
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement